当前位置: X-MOL 学术Arch. Physiol. Biochem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The role of resveratrol in diabetes and obesity associated with insulin resistance
Archives of Physiology and Biochemistry ( IF 2.5 ) Pub Date : 2021-03-15 , DOI: 10.1080/13813455.2021.1893338
Mustafa Hoca 1 , Eda Becer 2, 3 , Hafize Seda Vatansever 3, 4
Affiliation  

Abstract

Diabetes mellitus is a significant health problem that is caused by chronic hyperglycaemia as a result of inadequate insulin production or ineffective insulin action in the body. In recent years, many new pharmacological and non-pharmacological therapies have been developed for improving pancreatic insulin secretion and insulin resistance. Resveratrol is a natural and biologically active stilbenoid polyphenol present in various plant species and has the potential to benefit diabetes. The anti-diabetic actions of resveratrol have also been extensively studied in diabetic human and animal models. Moreover, resveratrol might affect insulin sensitivity by regulating visceral fat derivated adipokine levels. The use of resveratrol in combination with anti-diabetic therapies or alone may have significant potential for the management of diabetes mellitus. This review provides an overview of the anti-diabetic action of resveratrol as well as the possible mechanisms that have an effect on insulin secretion and insulin resistance in diabetics.



中文翻译:

白藜芦醇在与胰岛素抵抗相关的糖尿病和肥胖中的作用

摘要

糖尿病是一种严重的健康问题,是由体内胰岛素分泌不足或胰岛素作用无效引起的慢性高血糖症引起的。近年来,已经开发了许多新的药物和非药物疗法来改善胰腺胰岛素分泌和胰岛素抵抗。白藜芦醇是一种天然且具有生物活性的二苯乙烯类多酚,存在于各种植物物种中,有可能有益于糖尿病。白藜芦醇的抗糖尿病作用也已在糖尿病人和动物模型中得到广泛研究。此外,白藜芦醇可能通过调节内脏脂肪衍生的脂肪因子水平来影响胰岛素敏感性。将白藜芦醇与抗糖尿病疗法联合使用或单独使用可能具有治疗糖尿病的巨大潜力。

更新日期:2021-03-15
down
wechat
bug